Headache News and Research RSS Feed - Headache News and Research

Anesthetic administered with nasal spray effective in preventing pain during dental treatment

Anesthetic administered with nasal spray effective in preventing pain during dental treatment

A fear of pain causes many people with dental phobias to avoid or delay needed treatment. In some cases, the injection of a numbing agent can be the most painful part of the visit. [More]
High exposure to unconventional natural gas wells linked to migraine headaches, sinus and fatigue

High exposure to unconventional natural gas wells linked to migraine headaches, sinus and fatigue

New research suggests that Pennsylvania residents with the highest exposure to active natural gas wells operated by the hydraulic fracturing ("fracking") industry are nearly twice as likely to suffer from a combination of migraine headaches, chronic nasal and sinus symptoms and severe fatigue. [More]
Migraine patients differ from healthy people by increased vascular reactivity

Migraine patients differ from healthy people by increased vascular reactivity

A group of scientists from several Russian universities and medical centers made progress in explaining the nature of one of the most ancient neurologic diseases – migraine. The study was conducted within a larger project to develop a device capable of remotely and effectively diagnosing this disease. [More]
Teenagers who smoke daily report higher levels of health complaints

Teenagers who smoke daily report higher levels of health complaints

As fewer teens overall take up smoking, those who do smoke daily are reporting more health complaints than in years past, a new study indicates. [More]
Headache and migraine sufferers asked to self manage treatment as part of new Griffith research

Headache and migraine sufferers asked to self manage treatment as part of new Griffith research

Headache and migraine sufferers are being asked to self manage their own treatment as part of new research at Griffith University. [More]
FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes. [More]
Valley fever diagnosis often overlooked by primary care physicians

Valley fever diagnosis often overlooked by primary care physicians

For patients with pneumonia or ongoing influenza-like symptoms who live in or have visited the west or southwest United States, especially Arizona and central California, infectious diseases experts recommend physicians suspect valley fever, an often-overlooked fungal infection. [More]
NIAID begins early-stage trial of experimental vaccine for preventing yellow fever virus

NIAID begins early-stage trial of experimental vaccine for preventing yellow fever virus

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has begun an early-stage clinical trial of an investigational vaccine designed to protect against yellow fever virus. [More]
Researchers show porous silicon nanoparticles could be harmless to diagnose and treat cancer

Researchers show porous silicon nanoparticles could be harmless to diagnose and treat cancer

The Lomonosov Moscow State University researchers in collaboration with their German colleagues have succeeded in proving that silicon nanoparticles can be applied to diagnose and cure cancer. [More]
Study highlights effectiveness of atypical antipsychotic drug in treating children with TD

Study highlights effectiveness of atypical antipsychotic drug in treating children with TD

A meta-analysis of clinical trials evaluating the effectiveness of aripiprazole for the treatment of Tourette's disorder (TD) in children and adolescents showed a significantly greater overall improvement in total tics and tic severity from pretreatment to post-treatment for the aripiprazole compared to the placebo group. [More]
Soligenix announces encouraging preliminary results of heat stable Ebola vaccine

Soligenix announces encouraging preliminary results of heat stable Ebola vaccine

A biopharmaceutical company collaborating with Hawai'i scientists on an Ebola vaccine announced encouraging news about its vaccine today. [More]
Moderate strain to muscles, nerves can provoke CFS symptoms

Moderate strain to muscles, nerves can provoke CFS symptoms

A recent study conducted by researchers at the University of Alabama at Birmingham and Johns Hopkins University School of Medicine published in PLOS ONE shows that symptoms of chronic fatigue syndrome, a complex and disabling multisystem disorder, can be provoked by imposing a mild to moderate strain to the muscles and nerves. [More]
SLU researchers study investigational vaccine for yellow fever

SLU researchers study investigational vaccine for yellow fever

Saint Louis University's Center for Vaccine Development is studying an investigational vaccine for yellow fever, a potentially deadly disease that is spread by the same mosquito that transmits Zika virus. [More]
Noninvasive computer-based neurotechnology helps improve concussion symptoms in athletes

Noninvasive computer-based neurotechnology helps improve concussion symptoms in athletes

Brain State Technologies announces that a series of young athletes with long-term symptoms after concussion showed a variety of lasting improvements, after using HIRREM neurotechnology. [More]
FDA approves new ExAblate Neuro to treat patients with essential tremor

FDA approves new ExAblate Neuro to treat patients with essential tremor

The U.S. Food and Drug Administration today approved the first focused ultrasound device to treat essential tremor in patients who have not responded to medication. ExAblate Neuro uses magnetic resonance (MR) images taken during the procedure to deliver focused ultrasound to destroy brain tissue in a tiny area thought to be responsible for causing tremors. [More]
Non-drug solutions for postpartum depression: an interview with Dr David Brock & Christopher Thatcher

Non-drug solutions for postpartum depression: an interview with Dr David Brock & Christopher Thatcher

Postpartum depression (PPD) is reported to occur in 10-15% of delivering women with an estimated 400,000 women affected annually in the US. It is the most common complication of childbirth and is a significant public health concern. [More]
Aggressive home blood pressure monitoring may contribute to rise in emergency department visits

Aggressive home blood pressure monitoring may contribute to rise in emergency department visits

Visits to emergency departments for patients with hypertension increased by 64 percent between 2002 and 2012 while hospitalizations for those visits declined by 28 percent. [More]
European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year. [More]
Inhalable ibuprofen holds potential to treat cystic fibrosis

Inhalable ibuprofen holds potential to treat cystic fibrosis

Ibuprofen: You can buy it at any drug store, and it will help with that stabbing headache or sprained ankle. One of the ways it does so is by reducing inflammation, and it is this property that may also help patients with cystic fibrosis. [More]
Acupuncture improves headache-related QoL in TBI patients

Acupuncture improves headache-related QoL in TBI patients

A study comparing the effectiveness of usual care alone to usual care plus either auricular or traditional Chinese acupuncture in treating patients with headaches due to a previous traumatic brain injury (TBI) showed a significant improvement in headache-related quality of life (QoL) with the addition of acupuncture. [More]
Advertisement
Advertisement